FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Wockhardt buPROPion HCl Extended-Release Tablets Recall

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Ma…

Wockhardt Usa Inc. · Parsippany, NJ

Risk level
Class III
Reported by FDA
Aug 13, 2014
Recall ID
D-1513-2014
Check your lot numberHow we source this data

Summary

Wockhardt recalled buPROPion HCl Extended-Release Tablets starting Jul 14, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1513-2014 on Aug 13, 2014. Reason: Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.

Product description

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.

Lot numbers, UPCs & expiration codes

Lot #: DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1513-2014
Classification
Class III
Status
Terminated
Recall initiated
Jul 14, 2014
FDA report date
Aug 13, 2014
Quantity
840 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Wockhardt Usa Inc.

Original FDA data

Every field from FDA enforcement report D-1513-2014, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
68813
Address
20 Waterview Blvd., Suite 3
Code information
Lot #: DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14
Postal code
07054
Report date
Aug 13, 2014
Product type
Drugs
Recall number
D-1513-2014
Classification
Class III
Recalling firm
Wockhardt Usa Inc.
Product quantity
840 bottles
Termination date
Jan 12, 2015
Reason for recall
Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.
Distribution pattern
Nationwide
Recall initiation date
Jul 14, 2014
Initial firm notification
Letter
Center classification date
Aug 5, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1513-2014, published Aug 13, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls